|
|
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30
|
|
Download |
|
|
|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
107,850,000 |
Market
Cap: |
N/A |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$ - $ |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Vaxcyte is a clinical-stage vaccine company. Co. is developing conjugate and protein vaccines to treat bacterial infectious diseases. Co.'s primary vaccine candidate, VAX-24, is a 24-valent investigational pneumococcal conjugate vaccine (PCV) for the treatment of invasive pneumococcal disease and pneumonia. Co.'s second PCV candidate, VAX-XP, is designed to expand the breadth of coverage to greater than 30 strains without compromising immunogenicity due to carrier suppression. In addition, Co.'s pipeline includes VAX-A1, a conjugate vaccine candidate designed to treat Group A Strep and VAX-PG, a protein vaccine candidate targeting the keystone pathogen responsible for periodontitis.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
94,049 |
265,576 |
430,713 |
596,513 |
Total Sell Value |
$6,494,225 |
$18,639,582 |
$27,634,367 |
$32,139,570 |
Total People Sold |
5 |
7 |
7 |
9 |
Total Sell Transactions |
15 |
35 |
55 |
83 |
End Date |
2024-04-07 |
2024-01-05 |
2023-07-07 |
2022-07-07 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Lukatch Heath |
Director |
|
2022-11-10 |
4 |
AS |
$44.74 |
$199,989 |
D/D |
(4,335) |
3,125 |
|
- |
|
Lukatch Heath |
Director |
|
2022-11-10 |
4 |
OE |
$16.00 |
$69,360 |
D/D |
4,335 |
7,460 |
|
- |
|
Lukatch Heath |
Director |
|
2022-10-26 |
4 |
AS |
$38.25 |
$153,000 |
D/D |
(4,000) |
3,125 |
|
- |
|
Lukatch Heath |
Director |
|
2022-10-26 |
4 |
OE |
$16.00 |
$64,000 |
D/D |
4,000 |
7,125 |
|
- |
|
Lukatch Heath |
Director |
|
2022-10-24 |
4 |
AS |
$35.11 |
$105,857 |
D/D |
(3,015) |
3,125 |
|
- |
|
Lukatch Heath |
Director |
|
2022-10-24 |
4 |
OE |
$16.00 |
$48,240 |
D/D |
3,015 |
6,140 |
|
- |
|
Wassil Jim |
Chief Operating Officer |
|
2022-10-17 |
4 |
AS |
$25.31 |
$72,017 |
D/D |
(2,800) |
42,344 |
|
- |
|
Wassil Jim |
Chief Operating Officer |
|
2022-10-17 |
4 |
OE |
$2.42 |
$6,776 |
D/D |
2,800 |
45,144 |
|
- |
|
Fairman Jeff |
VP, Research |
|
2022-10-11 |
4 |
AS |
$25.50 |
$127,500 |
I/I |
(5,000) |
296,227 |
|
- |
|
Pickering Grant |
Chief Executive Officer |
|
2022-09-26 |
4 |
AS |
$24.68 |
$247,147 |
I/I |
(10,000) |
157,830 |
|
- |
|
Guggenhime Andrew |
President and CFO |
|
2022-09-19 |
4 |
AS |
$26.02 |
$80,898 |
D/D |
(3,100) |
37,538 |
|
- |
|
Guggenhime Andrew |
President and CFO |
|
2022-09-19 |
4 |
OE |
$5.35 |
$16,585 |
D/D |
3,100 |
40,638 |
|
- |
|
Wassil Jim |
Chief Operating Officer |
|
2022-09-19 |
4 |
AS |
$26.09 |
$73,111 |
D/D |
(2,800) |
42,344 |
|
- |
|
Wassil Jim |
Chief Operating Officer |
|
2022-09-19 |
4 |
OE |
$2.42 |
$6,776 |
D/D |
2,800 |
45,144 |
|
- |
|
Pickering Grant |
Chief Executive Officer |
|
2022-09-15 |
4 |
AS |
$27.95 |
$307,413 |
D/D |
(11,000) |
652,546 |
|
- |
|
Fairman Jeff |
VP, Research |
|
2022-09-06 |
4 |
AS |
$26.54 |
$132,892 |
I/I |
(5,000) |
301,227 |
|
- |
|
Pickering Grant |
Chief Executive Officer |
|
2022-09-02 |
4 |
D |
$26.38 |
$235,046 |
D/D |
(8,910) |
663,546 |
|
- |
|
Dhaliwal Harpreet S. |
SVP Cml Mfg & Supply Chain |
|
2022-09-02 |
4 |
D |
$26.38 |
$39,913 |
D/D |
(1,513) |
16,890 |
|
- |
|
Fairman Jeff |
VP, Research |
|
2022-09-02 |
4 |
D |
$26.38 |
$13,691 |
D/D |
(519) |
17,143 |
|
- |
|
Sauer Paul |
SVP Process Dev, Manufacturing |
|
2022-09-02 |
4 |
D |
$26.38 |
$22,819 |
D/D |
(865) |
13,822 |
|
- |
|
Wassil Jim |
Chief Operating Officer |
|
2022-09-02 |
4 |
D |
$26.38 |
$57,034 |
D/D |
(2,162) |
42,344 |
|
- |
|
Guggenhime Andrew |
President and CFO |
|
2022-09-02 |
4 |
D |
$26.38 |
$122,641 |
D/D |
(4,649) |
37,538 |
|
- |
|
Guggenhime Andrew |
President and CFO |
|
2022-08-29 |
4 |
AS |
$28.00 |
$494,284 |
D/D |
(17,653) |
42,187 |
|
- |
|
Guggenhime Andrew |
President and CFO |
|
2022-08-29 |
4 |
OE |
$5.35 |
$94,444 |
D/D |
17,653 |
59,840 |
|
- |
|
Pickering Grant |
Chief Executive Officer |
|
2022-08-26 |
4 |
AS |
$27.44 |
$274,416 |
I/I |
(10,000) |
162,830 |
|
- |
|
377 Records found
|
|
Page 7 of 16 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|